Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Nov;60(5):712–714. doi: 10.1038/bjc.1989.345

Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy.

C C Zielinski 1, C Müller 1, E Tichatschek 1, P Aiginger 1
PMCID: PMC2247293  PMID: 2508736

Full text

PDF
714

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blomgren H., Baral E., Edsmyr F., Strender L. E., Petrini B., Wasserman J. Natural killer activity in peripheral lymphocyte population following local radiation therapy. Acta Radiol Oncol. 1980;19(2):139–143. doi: 10.3109/02841868009130145. [DOI] [PubMed] [Google Scholar]
  2. Bonadonna G., Rossi A., Valagussa P., Banfi A., Veronesi U. The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. Cancer. 1977 Jun;39(6 Suppl):2904–2915. doi: 10.1002/1097-0142(197706)39:6<2904::aid-cncr2820390677>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  3. Greene W. C., Leonard W. J., Depper J. M., Nelson D. L., Waldmann T. A. The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann Intern Med. 1986 Oct;105(4):560–572. doi: 10.7326/0003-4819-105-4-560. [DOI] [PubMed] [Google Scholar]
  4. Harris J., Sengar D., Stewart T., Hyslop D. The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease. Cancer. 1976 Feb;37(2 Suppl):1058–1069. doi: 10.1002/1097-0142(197602)37:2+<1058::aid-cncr2820370813>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  5. Heppner G. H., Calabresi P. Selective suppression of humoral immunity by antineoplastic drugs. Annu Rev Pharmacol Toxicol. 1976;16:367–379. doi: 10.1146/annurev.pa.16.040176.002055. [DOI] [PubMed] [Google Scholar]
  6. Levy S., Herberman R., Lippman M., d'Angelo T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol. 1987 Mar;5(3):348–353. doi: 10.1200/JCO.1987.5.3.348. [DOI] [PubMed] [Google Scholar]
  7. Robb R. J., Greene W. C., Rusk C. M. Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J Exp Med. 1984 Oct 1;160(4):1126–1146. doi: 10.1084/jem.160.4.1126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rubin L. A., Jay G., Nelson D. L. The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol. 1986 Dec 15;137(12):3841–3844. [PubMed] [Google Scholar]
  9. Rubin L. A., Kurman C. C., Fritz M. E., Biddison W. E., Boutin B., Yarchoan R., Nelson D. L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985 Nov;135(5):3172–3177. [PubMed] [Google Scholar]
  10. SCHWARTZ R., EISNER A., DAMESHEK W. The effect of 6-mercaptopurine on primary and secondary immune responses. J Clin Invest. 1959 Aug;38(8):1394–1403. doi: 10.1172/JCI103915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tichatschek E., Zielinski C. C., Müller C., Sevelda P., Kubista E., Czerwenka K., Spona J., Wolf H., Eibl M. M. Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer. Cancer Immunol Immunother. 1988;27(3):278–282. doi: 10.1007/BF00205452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wang H. M., Smith K. A. The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med. 1987 Oct 1;166(4):1055–1069. doi: 10.1084/jem.166.4.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Zielinski C. C., Stuller I., Dorner F., Pötzi P., Müller C., Eibl M. M. Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy. Cancer. 1986 Oct 15;58(8):1648–1652. doi: 10.1002/1097-0142(19861015)58:8<1648::aid-cncr2820580812>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES